Dataset Information


MiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.

ABSTRACT: Uncontrolled extracellular matrix production by fibroblasts in response to tissue injury contributes to fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF), a progressive and ultimately fatal process that currently has no cure. Although dysregulation of miRNAs is known to be involved in a variety of pathophysiologic processes, the role of miRNAs in fibrotic lung diseases is unclear. In this study, we found up-regulation of miR-21 in the lungs of mice with bleomycin-induced fibrosis and also in the lungs of patients with IPF. Increased miR-21 expression was primarily localized to myofibroblasts. Administration of miR-21 antisense probes diminished the severity of experimental lung fibrosis in mice, even when treatment was started 5-7 d after initiation of pulmonary injury. TGF-beta1, a central pathological mediator of fibrotic diseases, enhanced miR-21 expression in primary pulmonary fibroblasts. Increasing miR-21 levels promoted, whereas knocking down miR-21 attenuated, the pro-fibrogenic activity of TGF-beta1 in fibroblasts. A potential mechanism for the role of miR-21 in fibrosis is through regulating the expression of an inhibitory Smad, Smad7. These experiments demonstrate an important role for miR-21 in fibrotic lung diseases and also suggest a novel approach using miRNA therapeutics in treating clinically refractory fibrotic diseases, such as IPF.


PROVIDER: S-EPMC2916139 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3349843 | BioStudies
2013-01-01 | S-EPMC3573122 | BioStudies
1000-01-01 | S-EPMC5457127 | BioStudies
1000-01-01 | S-EPMC3603596 | BioStudies
2018-01-01 | S-EPMC6127506 | BioStudies
1000-01-01 | S-EPMC3425828 | BioStudies
1000-01-01 | S-EPMC4048895 | BioStudies
1000-01-01 | S-EPMC4766462 | BioStudies
2020-01-01 | S-EPMC7139923 | BioStudies
2018-01-01 | S-EPMC5964221 | BioStudies